Challenges and best practices for cell-free long RNA biomarker discovery
Lluc Cabús, Julien Lagarde, Joao Curado, Esther Lizano & Jennifer Pérez-Boza Abstract The analysis of biomarkers in biological fuids, also known as liquid biopsies, is seen with great potential to diagnose complex diseases such as cancer with a high sensitivity...
Flomics initial employee gets CumLaude PhD in Biomedicine from UPF
Lluc has earned a Cum Laude PhD in Biomedicine from Pompeu Fabra University, marking a significant milestone for both himself and Flomics. As Flomics’ first PhD student and original team member, Lluc’s achievement is a testament to our company’s...
Flomics welcomes the Illumina NextSeq 2000 machine to our sequencing toolkit!
Flomics has recently acquired the Illumina NextSeq 2000, marking a significant milestone in our ongoing commitment to advancing next-generation sequencing and achieving scientific and technological excellence. The Illumina NextSeq 2000 is a powerful tool known for its...
€1.1 million funding round.
We are excited to announce the closing of a €1.1 million funding round to drive our innovative blood analysis for the early detection of five types of cancer (colorectal, lung, breast, prostate, and pancreatic). This funding round was led by a prominent US Family...
Second face-to-face meeting of the LiquiDx project consortium
The consortium led by Flomics Biotech, in which the Biobank of the Andalusian Public Health System (SSPA) and Leitat Technological Center participate, held its second annual coordination meeting at the Parc de Recerca Biomèdica de Barcelona (PRBB) on the 9 of...Internship Opportunities
Flomics is a fast-growing biotech company founded in 2018 in Barcelona, focused on the development of a revolutionary liquid biopsy solution for the early detection of cancer. Our technology is based on the analysis of cell-free RNA in blood, combining...
Petri: Flomics’ new 16S amplicon sequencing analysis pipeline on Stratus
By: Cristina Tuñi, MSc Bioinformatics Scientist Julien Lagarde, PhD Head of Bioinformatics 16S amplicon sequencing and metagenomics analysis have revolutionized the study of microbial communities 1. The availability of high-throughput sequencing technologies and new...
Flomics press release – PCPP 2022
Flomics celebrates International Day of Women and Girls in Science 2022
The International Day of Women and Girls happens every year on February 11 since 2015 and recognizes the critical role women and girls play in science and technology. Flomics fully supports science and gender equality and currently counts with 45% women in its...
Flomics COVID19 NGS platform update
Flomics Biotech continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of -FlomicsCOVID19– a cloud-based Next Generation Sequencing (NGS) platform for fast and automated analysis of COVID-19 NGS samples...